Papain-like cysteine proteinase zone (PCP-zone) and PCP structural catalytic core (PCP-SCC) of enzymes with cysteine proteinase fold.
COVID-19
Catalytic triad
Cysteine proteinases
Fold
Papain
SARC-CoV-2
Structural catalytic core
Zone
Journal
International journal of biological macromolecules
ISSN: 1879-0003
Titre abrégé: Int J Biol Macromol
Pays: Netherlands
ID NLM: 7909578
Informations de publication
Date de publication:
15 Dec 2020
15 Dec 2020
Historique:
received:
15
08
2020
revised:
13
09
2020
accepted:
03
10
2020
pubmed:
16
10
2020
medline:
18
12
2020
entrez:
15
10
2020
Statut:
ppublish
Résumé
There are several families of cysteine proteinases with different folds - for example the (chymo)trypsin fold family and papain-like fold family - but in both families the hydrolase activity of cysteine proteinases requires a cysteine residue as the catalytic nucleophile. In this work, we have analyzed the topology of the active site regions in 146 three-dimensional structures of proteins belonging to the Papain-like Cysteine Proteinase (PCP) superfamily, which includes papain as a typical representative of this protein superfamily. All analyzed enzymes contain a unique structurally closed conformation - a "PCP-Zone" - which can be divided into two groups, Class A and Class B. Eight structurally conserved amino acids of the PCP-Zone form a common Structural Core. The Structural Core, catalytic nucleophile, catalytic base and residue Xaa - which stabilizes the side-chain conformation of the catalytic base - make up a PCP Structural Catalytic Core (PCP-SCC). The PCP-SCC of Class A and Class B are divided into 5 and 2 types, respectively. Seven variants of the mutual arrangement of the amino-acid side chains of the catalytic triad - nucleophile, base and residue Xaa - within the same fold clearly demonstrate how enzymes with the papain-like fold adapt to the need to perform diverse functions in spite of their limited structural diversity. The roles of both the PCP-Zone of SARS-CoV-2-PLpro described in this study and the NBCZone of SARS-CoV-2-3CLpro presented in our earlier article (Denesyuk AI, Johnson MS, Salo-Ahen OMH, Uversky VN, Denessiouk K. Int J Biol Macromol. 2020;153:399-411) that are in contacts with inhibitors are discussed.
Identifiants
pubmed: 33058970
pii: S0141-8130(20)34644-4
doi: 10.1016/j.ijbiomac.2020.10.022
pmc: PMC7548629
pii:
doi:
Substances chimiques
Papain
EC 3.4.22.2
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1438-1446Informations de copyright
Copyright © 2020 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare no conflict of interest.
Références
Int J Biol Macromol. 2020 Oct 15;161:271-281
pubmed: 32512089
J Biol Chem. 2012 Mar 2;287(10):7388-98
pubmed: 22210776
Biomol Concepts. 2013 Jun;4(3):287-308
pubmed: 25436581
Antiviral Res. 2015 Mar;115:21-38
pubmed: 25554382
Planta. 2011 Aug;234(2):243-54
pubmed: 21416241
Nucleic Acids Res. 2000 Jan 1;28(1):235-42
pubmed: 10592235
J Biol Chem. 2005 Jan 14;280(2):1512-20
pubmed: 15531586
J Biol Chem. 2005 Dec 2;280(48):40058-65
pubmed: 16183633
Acta Crystallogr B. 1992 Feb 1;48 ( Pt 1):67-75
pubmed: 1616693
Acta Crystallogr D Biol Crystallogr. 2002 Jun;58(Pt 6 No 1):899-907
pubmed: 12037327
J Immunol. 2015 Jul 1;195(1):307-16
pubmed: 26026055
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2006 Jun 1;62(Pt 6):504-8
pubmed: 16754967
Vaccines (Basel). 2020 Jul 23;8(3):
pubmed: 32717854
Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):E653-61
pubmed: 23382230
Bioorg Med Chem Lett. 2015 Feb 1;25(3):438-43
pubmed: 25571794
Biochemistry. 2011 Dec 13;50(49):10732-42
pubmed: 22044167
PLoS One. 2020 Feb 21;15(2):e0229376
pubmed: 32084230
Bioinformatics. 1999 Apr;15(4):327-32
pubmed: 10320401
Biochemistry. 2016 May 31;55(21):3007-19
pubmed: 27030368
Nature. 1968 Jun 8;218(5145):929-32
pubmed: 5681232
Front Pharmacol. 2016 Apr 25;7:107
pubmed: 27199750
J Mol Biol. 1999 Mar 12;286(5):1633-49
pubmed: 10064720
Int J Mol Sci. 2020 May 15;21(10):
pubmed: 32429099
J Biol Chem. 2017 Sep 22;292(38):15622-15635
pubmed: 28751378
J Virol. 2010 Jul;84(13):6461-71
pubmed: 20410261
Proc Natl Acad Sci U S A. 2013 Feb 26;110(9):E838-47
pubmed: 23401522
Int J Biol Macromol. 2020 Jun 15;153:399-411
pubmed: 32151723
Biochemistry. 1996 Apr 2;35(13):3970-9
pubmed: 8672429
Nucleic Acids Res. 2014 Jan;42(Database issue):D304-9
pubmed: 24304899
Nature. 2020 Jun;582(7811):289-293
pubmed: 32272481
Trends Biochem Sci. 1998 Sep;23(9):347-52
pubmed: 9787641
FEBS J. 2009 Feb;276(3):793-806
pubmed: 19143838
Front Plant Sci. 2018 Dec 04;9:1717
pubmed: 30564252
J Mol Biol. 1995 Sep 15;252(2):248-62
pubmed: 7674305
J Mol Biol. 1994 Aug 5;241(1):83-93
pubmed: 8051710
J Biol Chem. 2008 Apr 18;283(16):11038-49
pubmed: 18270205
EMBO J. 1990 Jun;9(6):1939-47
pubmed: 2347312
J Virol. 2009 Nov;83(21):10931-40
pubmed: 19706710
Sci Adv. 2020 Oct 16;6(42):
pubmed: 33067239
Int J Biol Macromol. 2019 May 1;128:254-267
pubmed: 30664968